José Trevejo

Dr. José M.
Trevejo is a Chief Medical Officer at Q32 Bio, Inc. Dr. Trevejo was previously employed as a Chief Medical Officer by Tarsus Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by SmartPharm Therapeutics, Inc., a Vice President-Development by Visterra, Inc., a Medical Director by Genentech, Inc., a Medical Director by Vertex Pharmaceuticals (Canada), Inc., a Vice President-Clinical Development by Cyclerion Therapeutics, Inc., a Chief Development Officer by Rocket Pharmaceuticals, Inc., and a Principal Investigator & Scientist by The Charles Stark Draper Laboratory, Inc. He also served on the board at Diabetes Hands Foundation.
He received his undergraduate degree from the University of California, Los Angeles and a doctorate degree from Weill Cornell Medical College.